Abstract:Articular cartilage defects are a common source of joint pain and dysfunction. We hypothesized that sustained low-dose dexamethasone (DEX) delivery via an acellular osteochondral implant would have a dual pro-anabolic and anti-catabolic effect, both supporting the functional integrity of adjacent graft and host tissue while also attenuating inflammation caused by iatrogenic injury. An acellular agarose hydrogel carrier with embedded DEX-loaded poly(lactic-co-glycolic) acid (PLGA) microspheres (DLMS) was developed to provide sustained release for at least 99 days. The DLMS implant was first evaluated in an in vitro pro-inflammatory model of cartilage degradation. The implant was chondroprotective, as indicated by maintenance of Young's modulus (EY) (p = 0.92) and GAG content (p = 1.0) in the presence of interleukin-1β insult. In a subsequent preliminary in vivo experiment, an osteochondral autograft transfer was performed using a pre-clinical canine model. DLMS implants were press-fit into the autograft donor site and compared to intra-articular DEX injection (INJ) or no DEX (CTL). Functional scores for DLMS animals returned to baseline (p = 0.39), whereas CTL and INJ remained significantly worse at 6 months (p < 0.05). DLMS knees were significantly more likely to have improved OARSI scores for proteoglycan, chondrocyte, and collagen pathology (p < 0.05). However, no significant improvements in synovial fluid cytokine content were observed. In conclusion, utilizing a targeted DLMS implant, we observed in vitro chondroprotection in the presence of IL-1-induced degradation and improved in vivo functional outcomes. These improved outcomes were correlated with superior histological scores but not necessarily a dampened inflammatory response, suggesting a primarily pro-anabolic effect. STATEMENT OF SIGNIFICANCE: Articular cartilage defects are a common source of joint pain and dysfunction. Effective treatment of these injuries may prevent the progression of osteoarthritis and reduce the need for total joint replacement. Dexamethasone, a potent glucocorticoid with concomitant anti-catabolic and pro-anabolic effects on cartilage, may serve as an adjuvant for a variety of repair strategies. Utilizing a dexamethasone-loaded osteochondral implant with controlled release characteristics, we demonstrated in vitro chondroprotection in the presence of IL-1-induced degradation and improved in vivo functional outcomes following osteochondral repair. These improved outcomes were correlated with superior histological cartilage scores and minimal-to-no comorbidity, which is a risk with high dose dexamethasone injections. Using this model of cartilage restoration, we have for the first time shown the application of targeted, low-dose dexamethasone for improved healing in a preclinical model of focal defect repair.

Effects of Dexamethasone on Proliferation and Viability of Chondrocytes and Preventive Effect of Lactoferrin

Lactoferrin Inhibits Dexamethasone-Induced Chondrocyte Impairment from Osteoarthritic Cartilage Through Up-Regulation of Extracellular Signal-Regulated Kinase 1/2 and Suppression of FASL, FAS, and Caspase 3

Effects of lactoferrin on the proliferation, viability and extracellular signal regulated kinase expression in human osteoarthritis chondrocytes

[Effect of Different Concentrations of Dexamethasone on Apoptosis and Expression of Fas/FasL in Human Osteoarthritis Chondrocytes].

Effects of Dexamethasone Sodium Phosphate on the Proliferation of in Vitro Cultured Rabbit Articular Chondrocytes

The Chondroprotective Effects of Dehydroepiandrosterone Probably Exerted by Its Conversion to Estradiol

Effect of dexamethasone on proliferation of human periodontal ligament fibroblasts cultivated in vitro

Glucocorticoid caused lactic acid accumulation and damage in human chondrocytes via ROS-mediated inhibition of Monocarboxylate Transporter 4

Effects of dexamethasone on the functional properties of cartilage explants during long-term culture.

Effects of Dehydroepiandrosterone on Cultured Human Osteoarthritic Chondrocytes Induced by IL-1 Beta

Effect of dehydroepiandrosterone on experimental osteoarthritis in rabbits

The Disease-Modifying Effect of Dehydroepiandrosterone in Different Stages of Experimentally Induced Osteoarthritis: a Histomorphometric Study

Sustained low-dose dexamethasone delivery via a PLGA microsphere-embedded agarose implant for enhanced osteochondral repair

Long term usage of dexamethasone accelerating the initiation of osteoarthritis via enhancing the extracellular matrix calcification and apoptosis of chondrocytes

Lactoferrin Inhibits IL-1β-Induced Chondrocyte Apoptosis Through AKT1-Induced CREB1 Activation

Inhibitory Effects of Pharmacological Doses of Dexamethasone on Mineralization of Mesenchymal Progenitor Cells in Vitro.

Effect of dexamethasone on differentiation of human osteoblast and osteoclast in vitro

Comparative Evaluation Of The Effects Of Platelet-Rich Plasma Formulations On Extracellular Matrix Formation And The Nf-Kappa B Signaling Pathway In Human Articular Chondrocytes

Long term usage of dexamethasone accelerating accelerates the initiation of osteoarthritis via enhancing chondrocyte apoptosis and the extracellular matrix calcification and apoptosis of chondrocytes

The Effect of Anti-Inflammatory and Antifibrotic Agents on Fibroblasts Obtained from Arthrofibrotic Tissue AN IN VITRO AND IN VIVO STUDY

KLF2 reduces dexamethasone-induced injury to growth plate chondrocytes by inhibiting the Runx2-mediated PI3K/AKT and ERK signalling pathways